Low-Frequency Tibial Neuromodulation Increases Voiding Activity - a Human Pilot Study and Computational Model

This study combines a human pilot trial and a computational model to demonstrate that low-frequency tibial nerve stimulation (1 Hz) excites bladder activity while high-frequency stimulation (20 Hz) inhibits it, supporting a hypothesis that supraspinal mechanisms act as a high-pass filter to explain the frequency-dependent dual effects of TNS on voiding.

The Gist

The Big Idea: A Volume Knob for Your Bladder

Imagine your bladder isn't just a bag of water; it's a sophisticated security system connected to a control room in your brain. Usually, this system works like a high-pass filter (think of it like a bouncer at a club). The bouncer (your brainstem) only lets you feel the urge to pee when the "crowd" inside your bladder gets big enough.

For years, doctors have used a treatment called Tibial Nerve Stimulation (TNS) to help people who pee too much (overactive bladder). They zap a nerve in the ankle to tell the brain, "Hey, calm down, the bladder isn't full yet." It's like telling the bouncer to stand in front of the door and block everyone.

But this paper asks a fascinating question: What if you could turn the knob the other way? What if, instead of blocking the urge, you could speed it up to help people who can't pee at all (urinary retention)?

The researchers discovered that frequency matters.

• High Frequency (20 Hz): Like a heavy hand on the bouncer's shoulder. It shuts the door tight. (Good for overactive bladders).
• Low Frequency (1 Hz): Like whispering a secret to the bouncer to let a VIP in early. It actually opens the door faster. (Good for urinary retention).

---

Part 1: The Human Experiment (The "Thirsty Test")

The researchers wanted to see if this "whispering" trick worked on real humans.

The Setup:
They recruited healthy volunteers and gave them a big glass of water (750ml). Then, they waited for them to feel the urge to pee. But before that happened, they applied a small electrical zap to the nerve behind the ankle.

They split the group into three:

1. The "Slow Down" Group: Got a fast zap (20 Hz).
2. The "Speed Up" Group: Got a slow zap (1 Hz).
3. The "Fake" Group: Got no zap (Placebo).

The Results:

• The Placebo group waited a normal amount of time to feel the urge.
• The "Slow Down" group waited much longer. The zap successfully suppressed the urge.
• The "Speed Up" group felt the urge sooner than the placebo group.

The Analogy:
Imagine you are waiting for a bus.

• The Placebo group is waiting at the stop normally.
• The High-Frequency group is like someone putting a "Road Closed" sign on the street; the bus (the urge) never comes.
• The Low-Frequency group is like someone calling the bus driver to say, "Hey, we have a passenger waiting, come pick us up early!" The bus arrives sooner.

The Surprise:
Interestingly, while the time to feel the urge changed, the intensity of the urge (how desperate they felt) stayed about the same. It wasn't that the "Speed Up" group felt a stronger panic; they just felt the signal arrive earlier.

---

Part 2: The Computer Model (The "Digital Twin")

Because you can't stick electrodes inside a human brain to see what's happening, the researchers built a computer simulation of the bladder and its nervous system. Think of this as a flight simulator for peeing.

What the Computer Told Us:
The computer confirmed the human results but explained why it happened.

1. The Brainstem is a Filter: The model showed that the brainstem (specifically areas called the PAG and PMC) acts like a series of security gates.
2. How Low Frequency Works: When the computer applied the 1 Hz (Low) zap, it didn't just "excite" the bladder. Instead, it dampened the security guards at the brainstem. By quieting the guards, the "VIP" (the signal that the bladder is filling) could sneak through the gates faster than usual.
3. How High Frequency Works: The 20 Hz (High) zap overwhelmed the system, effectively locking all the gates and silencing the signal completely.

The "Contraction" Secret:
The computer also noticed something cool: When the low-frequency zap worked, the bladder didn't just signal "go" earlier; when it finally did go, it squeezed harder and longer. It was a more efficient "squeezing" event.

---

Why Does This Matter? (The Real-World Impact)

Currently, if someone has Urinary Retention (they can't pee, often after surgery or due to nerve damage), the only non-invasive options are very limited. They often have to use a catheter (a tube), which is uncomfortable and can cause infections.

This study suggests a new, non-invasive way to help them:

• The "Acute" Treatment: Instead of waiting weeks for a treatment to work, doctors might be able to zap the ankle with Low Frequency (1 Hz) right when the patient needs to pee. This could act as a "kickstart" to help the bladder empty on its own, potentially reducing the need for catheters.

Summary in One Sentence

This paper proves that by changing the speed of an electrical zap on the ankle nerve, we can either pause the urge to pee (high speed) or trigger it earlier and more efficiently (low speed), offering a potential new, non-invasive cure for people who can't empty their bladders.

Technical Summary

1. Problem Statement

Transcutaneous Tibial Nerve Stimulation (TTNS) is a widely adopted clinical intervention for treating overactive bladder (OAB) and urinary incontinence. The prevailing understanding is that TTNS works by inhibiting bladder activity via the suppression of brainstem and spinal cord reflexes, typically using high-frequency stimulation (e.g., 20 Hz).

However, a critical gap exists in the literature regarding the frequency-dependent effects of TTNS. Preliminary animal studies suggested that while high-frequency stimulation inhibits bladder activity, low-frequency stimulation might paradoxically excite (up-regulate) bladder activity. This excitatory effect is poorly understood mechanistically and has not been rigorously validated in humans. Furthermore, there is a lack of non-invasive treatment options for non-obstructive urinary retention (NOUR), a condition where patients cannot void effectively.

2. Methodology

The study employed a dual-pronged approach combining a human pilot clinical trial with a computational systems biology model.

A. Human Pilot Study

• Design: Single-blind, randomized, between-subjects trial involving healthy adult participants ($N=43$ after exclusions).
• Protocol:
  • Participants ingested 750ml of water after emptying their bladders and underwent a 30-minute digestion period.
  • Group A (Low-Frequency): Received 1 Hz TTNS (200 µs pulse width, motor threshold).
  • Group B (Control): No stimulation (sham).
  • Group C (High-Frequency): Received 20 Hz TTNS (200 µs pulse width, motor threshold).
  • Stimulation Site: 1 cm posterior and 10 cm superior to the medial malleolus.
  • Outcome Measures: Time elapsed to first urge to urinate and subjective urge intensity (rated 0–4).
  • Washout: An optional 10-minute period followed to test for lingering effects.
• Analysis: Due to small sample sizes and non-normal data distribution, the authors utilized Bayesian Robust Linear Regression and Region of Practical Equivalence (ROPE) analysis rather than traditional frequentist statistics.

B. Computational Model

• Architecture: A conductance-based neural network model simulating the lower urinary tract control circuit, adapted from previous work (Lister et al., 2019).
  • Components: Modeled the Periaqueductal Grey (PAG), Pontine Micturition Centre (PMC), spinal interneurons, and efferent pathways (Pelvic, Hypogastric, Pudendal).
  • Bladder Physics: A biophysical bladder model calculating internal pressure ($P_B$) based on efferent firing rates.
  • Neurons: Implemented using the Conductance-Based Adaptive Exponential Integrate-and-Fire (CAdEx) model, including opioidergic inhibition mechanisms.
• Simulation:
  • Simulated 500-second trials across 21 frequencies (0–20 Hz).
  • Intervention: "Severed" specific tibial nerve projections (spinal vs. brainstem targets) to isolate the mechanism of action.
• Training: Model parameters were fitted using real bladder pressure and neural data from Wistar rats (Jabbari et al., 2019) via Bayesian optimization.

3. Key Contributions

1. First Human Evidence of Excitatory TTNS: The study provides the first empirical evidence in humans that low-frequency (1 Hz) TTNS can up-regulate bladder activity (inducing urge faster), while high-frequency (20 Hz) TTNS down-regulates it (delaying urge).
2. Mechanistic Hypothesis (The "Filter" Model): The authors propose that the brainstem (PAG/PMC) acts as a high-pass filter for afferent sensory signals. Low-frequency stimulation inhibits the feedback loops within these filters, lowering the threshold required to trigger voiding, thereby allowing smaller afferent signals to pass through and initiate voiding.
3. In Silico Validation: The computational model successfully replicated the frequency-dependent effects observed in humans, confirming that the excitatory effect is mediated specifically by brainstem-targeting projections rather than spinal projections alone.
4. Clinical Implications for Urinary Retention: The findings suggest a novel, non-invasive therapeutic strategy for urinary retention (NOUR) using acute, low-frequency TTNS to facilitate voiding, contrasting with the chronic, high-frequency protocols used for incontinence.

4. Key Results

Human Study Findings

• Urge Onset Time:
  • Low-Frequency (1 Hz): Significantly reduced time to first urge (Mean $\approx$ 937s) compared to control (Mean $\approx$ 1277s). Bayesian analysis indicated an 89.28% probability of a real effect.
  • High-Frequency (20 Hz): Significantly delayed urge onset (Mean $\approx$ 2301s) compared to control. Bayesian analysis indicated a 99.94% probability of delay.
• Urge Intensity: No significant difference in the intensity of the urge was found between groups at the moment of reporting. The primary effect was on the timing of the sensation, not its magnitude.
• Washout: No lingering effects were observed after the 10-minute washout period.

Computational Model Findings

• Frequency Dependence: The model confirmed that 1 Hz stimulation increased voiding efficiency (from ~9.5% to ~41.4%) and shortened the time to void, while 20 Hz completely inhibited voiding.
• Mechanism of Excitation:
  • The excitatory effect was driven by an increase in the duration of bladder contractions.
  • Projections: The effect was dependent on brainstem (PAG/PMC) projections. Severing spinal projections alone did not abolish the effect, but severing brainstem projections did.
  • Filtering: The model supports the hypothesis that low-frequency TNS inhibits the PAG/PMC feedback loops, effectively "opening the gate" for afferent signals to trigger the micturition reflex earlier.
• Limitations: The model showed lower bladder capacity and voiding efficiency than human physiology (due to rat training data), but successfully captured the switching behavior between storage and voiding.

5. Significance and Future Directions

• Paradigm Shift: This work challenges the dogma that TTNS is solely an inhibitory therapy. It demonstrates that stimulation frequency is a critical parameter that can switch the system between inhibition (for incontinence) and excitation (for retention).
• Treatment for Urinary Retention: The results offer a promising, non-invasive, acute treatment for Non-Obstructive Urinary Retention (NOUR). Instead of prophylactic weekly sessions, patients could potentially use acute, low-frequency stimulation at the point of voiding to reduce catheter dependency and infection risks.
• Mechanistic Insight: The identification of the brainstem as a "high-pass filter" provides a concrete neural target for future research and device optimization.
• Next Steps: The authors call for clinical trials in pathological populations (specifically NOUR patients) to validate the efficacy of acute, low-frequency TTNS and to further disentangle the complex interactions between spinal and supraspinal pathways during high-frequency inhibition.

Conclusion: The study successfully bridges the gap between animal models and human physiology, validating a frequency-dependent duality in tibial neuromodulation. It establishes a foundation for developing targeted, frequency-specific neuromodulation therapies for a broader spectrum of lower urinary tract dysfunctions.